- Lung cancer
- Mesothelioma
Melina Elpi Marmarelis, MD
About me
- Medical Director, Penn Mesothelioma Program
- Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
My education and training
- Harvard Medical SchoolMedical School
- Massachusetts General Hospital/Brigham and Women’s HospitalResidency
- University of Pennsylvania Health SystemResidency
Spoken languages
Reviews
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Internal Medicine, 2017
- Medical Oncology, 2019
- ASCO Cancer.Net, National
- Academic Thoracic Oncology Medical Investigators Consortium, International
- American Society of Clinical Oncology, National
- AstraZeneca, International
- Cancer Research UK, International
- Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP) Mesothelioma panel, National
- International Association for the Study of Lung Cancer, International
- Mesothelioma Applied Research Foundation, National
- Lung cancer care
Treatments and conditions
Research
Publications
W. Wang, D. Huth, C. Davis, X. Wang, D. Cantor, A. Singh, L. Sun, C. D’Avella, D. Dougherty, K. Robinson, R. Cohen, C. Langer, M. Marmarelis, C. Aggarwal P2.091Real-World Implementation of Tumor-Informed ctDNA MRD Testing in Early-Stage NSCLC: Initial Experience From a Large Academic Center , WCLC 2026 Poster: 2026
X. Wang; A. Martella; A. Watts; E.P. Wileyto; P. Gabriel; A. Montgomery; K. Rendle; M. Marmarelis; C. Aggarwal P2.092 - Inudge: Integration of Liquid Biopsy Based Next Generation Gene Sequencing in Newly Diagnosed NSCLC - Results From a Prospective Clinical Trial , WCLC 2026 Poster: 2026
Kleeman SO, Riazat-Kesh Y, Carvajal R, Marmarelis ME, Schadendorf D, Sharon E, Othus M, Robert C, Skoulidis F, Izar B, Maki RG, Janowitz T. Cancer Chemoimmunotherapy: Time Will Tell , Cancer Immunol Res, 14: 2026,1212-1215
Barsouk AA, Yaskolko M, Sussman JH, Sun L, Singh AP, Cohen RB, Aggarwal C, Marmarelis ME, Langer CJ. Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC , Clin Lung Cancer, 27: 2026,50-55
Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Tyler Marquart, Sam Whipple, Yufei Wang, Taylor J Allen-Coyle, Naleen Raj Bhandari, Charu Aggarwal The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC , Cancers, 18(14): 2026,2287
Sam O. Kleeman; Yosef Riazat-Kesh; Richard Carvajal; Melina E. Marmarelis; Dirk Schadendorf; Elad Sharon; Megan Othus; Caroline Robert; Ferdinandos Skoulidis; Benjamin Izar; Robert G. Maki; Tobias Janowitz. Cancer chemo-immunotherapy: time will tell , Cancer Immunology Research: 2026
Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Aditi P. Singh, Melina E. Marmarelis Carboplatin plus Pemetrexed versus Pemetrexed alone in Advanced Thymoma and Thymic Carcinoma: A Retrospective Cohort Study , Frontiers: 2026
Benjamin A. Bleiberg, Dylan G. Scholes, Lauren Reed-Guy, Devaki Dravid, Lova L. Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis, Charu Aggarwal The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing , The Journal of Liquid Biopsy, 12: 2026
Bleiberg BA, Scholes DG, Reed-Guy L, Dravid D, Sun LL, Singh AP, Cohen RB, Langer CJ, Marmarelis ME, Aggarwal C. Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461] , J Liq Biopsy, 12: 2026,100472
Cole Friedes, Michelle Iocolano, Nikhil Yegya-Raman, John C Kucharczuk, Taine T V Pechet, Roger B Cohen, Charu Aggarwal, Melina E Marmarelis, William P Levin, Keith A Cengel, Christine A Ciunci, Christopher D'Avella, Aditi P Singh, Christiana W Davis, Corey J Langer, Jeffrey Bradley, Steven J Feigenberg Real World Radiographic Response Rates and Preoperative Attrition in Patients With Non-Small Cell Lung Cancer (NSCLC) Treated With Neoadjuvant Chemoimmunotherapy , American Journal of Clinical Oncology: 2026